Coronary Heart Disease Treatments

Find Coronary Heart Disease Treatments

Living with Coronary Heart Disease (CHD) can bring anxiety and uncertainty, especially when dealing with symptoms like chest pain (angina) or shortness of breath. CHD occurs when the major blood vessels supplying the heart become damaged and narrowed by plaque buildup, a process called atherosclerosis. This limits the essential supply of oxygen-rich blood to the heart muscle, affecting your energy, activity level, and overall comfort.

Treatment is vital to improve heart function, relieve painful symptoms, and, most importantly, prevent life-threatening events like heart attacks. While the underlying plaque cannot be completely removed with medication, drug therapies are highly effective at controlling related risk factors and slowing the disease’s progression. Because the severity of blockages and the presence of other conditions (like high blood pressure or diabetes) vary, treatment plans are always highly customized to the individual’s needs (American Heart Association, 2024).

Overview of treatment options for Coronary Heart Disease

The overall treatment strategy for CHD is aggressive and multi-faceted, aiming to target both the symptoms and the underlying cause of the plaque buildup. The main goals are to relieve angina pain, control cardiovascular risk factors (cholesterol, blood pressure), and minimize the risk of blood clots forming on the plaques.

For all patients, treatment begins with significant lifestyle changes, including dietary modification and increased physical activity. However, medication is the necessary foundation for most patients with established CHD. Drug classes are used long-term to keep the disease stable. Procedures, such as angioplasty (stenting) or bypass surgery, are reserved for cases where blood flow is critically blocked and medication alone cannot manage symptoms or risk.

Medications used for Coronary Heart Disease

Medications for CHD are organized into groups that address specific components of the disease:

  • Cholesterol-Lowering Drugs: Statins are the primary medication class used. Examples include simvastatin and atorvastatin. These are critical not just for lowering LDL (“bad”) cholesterol but also for stabilizing the plaque inside artery walls, reducing the risk of rupture.
  • Antiplatelet Drugs: These drugs reduce the likelihood of harmful blood clots forming. Aspirin is commonly prescribed for most CHD patients. For higher-risk cases, a second agent, such as clopidogrel, may be added temporarily.
  • Blood Pressure-Lowering Drugs: Beta-blockers (e.g., metoprolol) and ACE inhibitors (e.g., lisinopril) are widely used. Beta-blockers help the heart beat slower and with less force. ACE inhibitors relax blood vessels and lower pressure.
  • Angina Relief: Nitrates are used to relieve chest pain. Short-acting nitrates (like nitroglycerin) work quickly to relax arteries when angina strikes. Long-acting nitrates help prevent pain throughout the day.

Studies show that consistent adherence to cholesterol-lowering and blood pressure medications provides the greatest reduction in heart attack and stroke risk over time (National Heart, Lung, and Blood Institute, 2022).

How these medications work

Statins lower cholesterol production and circulation, reducing plaque growth. Crucially, they also stabilize existing plaque through anti-inflammatory effects, preventing rupture and clotting.

Antiplatelet drugs, like Aspirin, prevent blood platelets from sticking together to form clots, a common cause of heart attacks, by inhibiting a specific chemical signal.

Blood pressure medications lessen the heart’s workload. Beta-blockers reduce heart rate and force by blocking adrenaline. ACE inhibitors ease blood flow by preventing the production of vessel-narrowing hormones. Nitrates immediately increase blood flow to the heart muscle by rapidly relaxing and widening blood vessels.

Side effects and safety considerations

CHD medications require close monitoring. Statins can cause muscle aches or liver problems, necessitating periodic blood tests. Antiplatelet drugs increase bleeding risk; patients must report unusual bruising or blood in the stool.

Beta-blockers may cause fatigue, slow heart rate, or cold extremities. ACE inhibitors can cause a dry cough. Nitroglycerin often causes headaches or dizziness from sudden blood pressure drops.

Patients with CHD should immediately call 911 for new or worsening chest pain, crushing chest pressure, or pain radiating to the jaw or arm, as these signal an acute heart attack. Since everyone’s experience with the condition and its treatments can vary, working closely with a qualified healthcare provider helps ensure safe and effective care.

References

  1. American Heart Association. https://www.heart.org
  2. National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov
  3. Mayo Clinic. https://www.mayoclinic.org
  4. MedlinePlus. https://medlineplus.gov

Medications for Coronary Heart Disease

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Coronary Heart Disease.

Found 22 Approved Drugs for Coronary Heart Disease

Atorvastatin

Brand Names
Amlodipine, Amlodipine Besylate, Atorvaliq, Azor, Benazepril, Benicar, Caduet, Katerzia, Lipitor, Lotensin, Lotrel, Norliqva, Norvasc, Olmesartan Medoxomil, Olmesartan Medoxomil Amlodipine, Sdamlo, Tribenzor

Atorvastatin

Brand Names
Amlodipine, Amlodipine Besylate, Atorvaliq, Azor, Benazepril, Benicar, Caduet, Katerzia, Lipitor, Lotensin, Lotrel, Norliqva, Norvasc, Olmesartan Medoxomil, Olmesartan Medoxomil Amlodipine, Sdamlo, Tribenzor
Amlodipine and benazepril hydrochloride capsules are a combination capsule of amlodipine, a dihydropyridine calcium channel blocker (DHP CCB) and benazepril, an angiotensin-converting enzyme (ACE) inhibitor. Amlodipine and benazepril hydrochloride capsules are indicated for the treatment of hypertension in patients not adequately controlled on monotherapy with either agent.

Asprin

Generic Name
Dipyridamole

Asprin

Generic Name
Dipyridamole
Aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. Aspirin and extended-release dipyridamole capsules are a combination of aspirin and dipyridamole, antiplatelet agents, indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis ( 1 )

TC99M Sestamibi

Brand Names
99M Sestamibi, Cardiolite

TC99M Sestamibi

Brand Names
99M Sestamibi, Cardiolite
Myocardial Imaging: Kit for the preparation of Technetium Tc 99m Sestamibi Injection is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing information for use in patient management decisions. Technetium Tc 99m Sestamibi evaluation of myocardial ischemia can be accomplished with rest and cardiovascular stress techniques (e.g., exercise or pharmacologic stress in accordance with the pharmacologic stress agents labeling). It is usually not possible to determine the age of a myocardial infarction or to differentiate a recent myocardial infarction from ischemia. Breast Imaging: Kit for the preparation of Technetium Tc 99m Sestamibi Injection is indicated for planar imaging as a second line diagnostic drug after mammography to assist in the evaluation of breast lesions in patients with an abnormal mammogram or a palpable breast mass. Kit for the preparation of Technetium Tc 99m Sestamibi Injection is not indicated for breast cancer screening, to confirm the presence or absence of malignancy, and it is not an alternative to biopsy. Technetium Tc 99m Sestamibi, is a myocardial perfusion agent indicated for: detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects) ( 1 ) evaluating myocardial function and developing information for use in patient management decisions ( 1 )

BiDil

Generic Name
Isosorbide

BiDil

Generic Name
Isosorbide
BiDil is a combination of isosorbide dinitrate, a nitrate vasodilator, and hydralazine hydrochloride, an arteriolar vasodilator, indicated for: the treatment of heart failure as an adjunct therapy to standard therapy in self-identified black patients to improve survival, prolong time to hospitalization for heart failure and to improve patient-reported functional status.

Pravastatin

Generic Name
Pravastatin

Pravastatin

Generic Name
Pravastatin
Pravastatin sodium tablets are indicated: Pravastatin sodium tablets are an HMG-CoA reductase inhibitor (statin) indicated ( 1 ): To reduce the risk of myocardial infarction, myocardial revascularization procedures, and cardiovascular mortality in adults with elevated low-density lipoprotein cholesterol (LDL-C) without clinically evident coronary heart disease (CHD)., To reduce the risk of coronary death, myocardial infarction, myocardial revascularization procedures, stroke or transient ischemic attack, and slow the progression of coronary atherosclerosis in adults with clinically evident CHD., As an adjunct to diet to reduce LDL-C in adults with primary hyperlipidemia., As an adjunct to diet to reduce LDL-C in pediatric patients ages 8 years and older with heterozygous familial hypercholesterolemia (HeFH)., As an adjunct to diet for the treatment of adults with:, Primary dysbetalipoproteinemia., Hypertriglyceridemia.
Showing 1-5 of 22
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances